These executive summaries provide an annual account of progress against the objectives of Australia’s National Blood borne Virus (BBV) and Sexually Transmissible Infections (STIs) Strategies. The targets and associated objectives of the National Strategies are to improve testing, treatment and uptake of preventative measures for hepatitis B, hepatitis C, STIs and HIV, and to reduce the incidence, morbidity, mortality and personal and social impacts they cause. Each objective has a series of measurable indicators for monitoring progress. This report describes the targets, objectives and indicators of the National Strategies, and the level of progress being made in response. It provides measurement of the effectiveness of our national response and highlights areas requiring attention.
Tracking the Progress 2021: Executive Summaries
Tracking the Progress 2021: National HIV Strategy
Tracking the Progress 2021: National Hepatitis B Strategy
Tracking the Progress 2021: National Hepatitis C Strategy
Tracking the Progress 2021: National STI Strategy
Tracking the Progress 2024: National Aboriginal and Torres Strait Islander BBV and STI Strategy